 |
 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about MZM.
Condition  |
Reviews | Compare | Avg. Ratings |
|---|---|---|---|
| Glaucoma | 0 reviews | 40 medications | Not rated - Be the first |
No reviews have yet been submitted. Be the first to review this drug.
Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza Suspension, indicated for the reduction of elevated...
Drugs and surgery can lower the hallmark inner-eye pressure characteristic of glaucoma -- the second-leading cause of blindness in the United States. But...
The prevalence of glaucoma in the United States is 22 percent higher than it was 10 years ago, a new report reveals. Researchers from Prevent Blindness...
Looking for answers? Ask a question
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
